- Addex Shareholders Approve All Resolutions at Annual General Meeting
- Addex Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
- Addex Reports Q1 2023 Financial Results and Provides Corporate Update
- Addex Announces ADX71149 Phase 2 Epilepsy Clinical Study’s Independent Interim Review Committee Recommends Continuing Study
- Addex Convenes Annual General Meeting 2023
- Addex Therapeutics to Release Q1 2023 Financial Results and Host Conference Call on May 11, 2023
- Addex Completes $5.0 Million Equity Financing
- Addex Publishes Dipraglurant Data Showing In Vivo Efficacy on Motor and Non-Motor Symptoms of Parkinson’s Disease
- Addex Raises $5.0 Million in Equity Financing
- Addex Reports Full Year 2022 Financial Results and Provides Corporate Update
More ▼
Key statistics
As of last trade, Addex Therapeutics Ltd (ADXN:SWX) traded at 0.115, 14.31% above the 52 week low of 0.1006 set on Dec 30, 2022.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.12 |
---|---|
High | 0.12 |
Low | 0.11 |
Bid | 0.1085 |
Offer | 0.115 |
Previous close | 0.12 |
Average volume | 166.23k |
---|---|
Shares outstanding | 115.35m |
Free float | 110.60m |
P/E (TTM) | -- |
Market cap | 13.84m CHF |
EPS (TTM) | -0.3778 CHF |
Data delayed at least 15 minutes, as of Jun 05 2023 15:19 BST.
More ▼